anti-melanoma mab fragments
Various (V09)Various (V09) compound in Piramal Critical Care's portfolio. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
pharma · Melanoma
Piramal Critical Care
Piramal Critical Care B.V.
Piramal Critical Care drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Bethlehem, USA HQ
339 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Bethlehem, USA
- Employees
- 339
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Piramal Critical Care pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Piramal Critical Care drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.